glp 1 and heart disease Early trials of GLP-1 based drugs have shown promising results in patients with failure with preserved ejection fraction., A new study in JAMA uses real-world evidence that complements these Cardiovascular benefits of glucagon-like peptide-1

These trials have shown that participants using semaglutide, in conjunction with lifestyle changes, can achieve substantial weight loss

doi: 10.1016/j.psychres.2019.112727 154 KriSSzabCKelemenO

Starting with microdosing offers flexibility

169 Some evidence suggests omega-3 fatty acids may lower the risk of anovulation, increase ovarian reserve, and improve oocyte quality and embryo development

Look for symptoms of low blood sugar levels, such as rapid heart rate, confusion, lightheadedness, nervousness, dizziness, chills, and sweating

While compounded medications themselves are not FDA-approved in the same way branded drugs are, the pharmacies making them must follow strict quality standards